Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America.
Rojas JI, Patrucco L, Fruns M, Hornung G, Flores J, Carnero Contentti E, Lopez PA, Pettinicchi JP, Caride A, Galleguillos L, Barahona J, Diaz V, Hernández M, Alonso R, Cristiano E.
Rojas JI, et al. Among authors: diaz v.
Arq Neuropsiquiatr. 2021 Apr;79(4):305-309. doi: 10.1590/0004-282X-ANP-2020-0339.
Arq Neuropsiquiatr. 2021.
PMID: 34133511
Free PMC article.